2American Thoracic Society Documents. Guidelines for the manage - ment of adults with hospital - acquired, ventilator - associated and healthcare-associated pneumonia [ J ]. Am J Respir Crit Care Med, 2005, 171 (4): 388-416.
3Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator - associated pneumonia [ J ]. Chest, 1997, 111: 676-685.
4Trouillet JL, Vuagnat A, Combes A, et al. Pseudomonas aeruginosa ventilator - associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin -susceptible organisms [ J ]. Clin Infect Dis, 2002, 34:1047 -1054.
5Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilatorassociated pneumonia [ J ]. Crit Care Med, 2001, 29:1109 -1115.
6Fink MP, Snydman DR, Niederman MS, et al. Severe Pneumonia Study Group. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, doubleblind trial comparing intravenous ciprofloxacin with imipenem - cilastatin [ J ]. Antimicrob Agents Chemother, 1994, 38:547-557.
7American Thoracic Society. Hospital - acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies [J]. Am J Respir Crit Care Med, 1996, 153: 1711 - 1725.
8Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics [J]. Am J Med, 1991, 91 : 462 -470.
9Hamer, DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug - resistant Pseudomonas aeruginosa with aerosolized colistin [J]. Am J Respir Crit Care Med, 2000, 162:328 -330.
10Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator - associated pneumonia in adults : a randomized trial [J]. JAMA, 2003, 290: 2588-2598.
